| Article | Added |
|---|
| Model N to Present at the Raymond James Internet & Software Crossover Conference | 05-24-13 |
| BioNJ Announces Keynote Speakers for BioP 4th Annual International BioPartnering Conference | 05-24-13 |
| Digital Pathology Systems Sector Discussed in Comprehensive Global Industry Analysts Study Published at MarketPublishers.com | 05-24-13 |
| Company Profile for AIBioTech | 05-24-13 |
| La tecnologia di denervazione renale EnligHTN è in grado di ridurre la pressione arteriosa in maniera sicura, rapida e sostenuta, secondo i dati relativi al periodo di un anno derivati dallo studio di St. Jude Medical. | 05-24-13 |
| Impax Laboratories to Present at the Deutsche Bank 38th Annual Health Care Conference | 05-24-13 |
| Research and Markets: Closed Drug Transfer Systems: Oncology Therapeutics Market Dynamics and Closed Drug Transfer Design Factors | 05-24-13 |
| KCI????V.A.C.®??????Prevena? Peel & Place??? | 05-24-13 |
| Samenvatting: Covidien publiceert resultaten eerste in-human studie van nieuwe met medicatie bedekt ballon | 05-24-13 |
| Resumen: Covidien publica los resultados del primer estudio en humanos del nuevo balón recubierto con fármacos | 05-24-13 |
| Antares Pharma to Present at the Deutsche Bank Securities, Inc. 38th Annual Health Care Conference | 05-24-13 |
| Covidien Board of Directors Approves Separation of Pharmaceuticals Business and Declares Dividend of Mallinckrodt Ordinary Shares | 05-24-13 |
| Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan | 05-24-13 |
| ????????????????????????????????????????????????????????? | 05-24-13 |
| Boehringer Ingelheim and Eli Lilly & Company launch type 2 diabetes educational game, ?Complications Combat? | 05-24-13 |
| BioInvent Recruits Michael Oredsson as New CEO | 05-24-13 |
| Einjahresdaten aus Studie von St. Jude Medical zeigen sichere, schnelle und nachhaltige Blutdrucksenkung mit EnligHTN-Technologie für renale Denervierung | 05-24-13 |
| BioInvent recruits Michael Oredsson as new CEO | 05-24-13 |
| Covidien meldet Ergebnisse der ersten Studie zu neuem medikamentenbeschichtetem Ballonkatheter am Menschen | 05-24-13 |
| Covidien Releases Results from First-in-Human Study of New Drug-Coated Balloon | 05-24-13 |
| Riassunto: Covidien pubblica i risultati del primo studio sull'uomo del nuovo palloncino per insufflazione ricoperto con farmaco | 05-24-13 |
| Covidien publie les résultats de l?étude du nouveau ballon à élution testé pour la première sur des sujets humains | 05-24-13 |
| Merck Provides Update on Phase III Clinical Program for Preladenant, the Company's Investigational Parkinson's Disease Medicine | 05-23-13 |
| Anacor Pharmaceuticals to Present at Deutsche Bank's 38th Annual Healthcare Conference | 05-23-13 |
| Cubist to Present at Jefferies 2013 Global Healthcare Conference | 05-23-13 |
| Elan Announces Pricing of US$850 Million in Aggregate Principal Amount of Senior Notes Due 2021 | 05-23-13 |
| Agilent Technologies Announces Cash Dividend of 12 Cents Per Share | 05-23-13 |
| Interleukin Genetics to Discuss Corporate Update and First Quarter Results | 05-23-13 |
| Alkermes? Corporate Presentation to be Webcast at the Deutsche Bank 38th Annual dbAccess Health Care Conference | 05-23-13 |
| RTI Biologics® Announces Milestone in Tissue Processing: More than 5 Million Implants Sterilized with Zero Incidence of Implant-Associated Infection | 05-23-13 |
| City of Mason and Top Gun Sales Launch One-of-a-Kind Tech Hub | 05-23-13 |
| Announcing The EdisonHealth Network LLC, a Breakthrough Approach to Centers of Excellence for Complex Surgeries | 05-23-13 |
| Samenvatting: Biogen Idec benoemt Spyros Artavanis-Tsakonas tot Chief Scientific Officer | 05-23-13 |
| New U.S. Study Indicates That Biomet's Oxford Partial Knee Patients Were More Likely to Be Satisfied Than Total Knee Patients in Ability to Perform Activities of Daily Living | 05-23-13 |
| Elan Corporation, plc's Board of Directors Unanimously Reject Royalty Pharma's Revised Tender Offer | 05-23-13 |
| Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris | 05-23-13 |
| Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference | 05-23-13 |
| Senior Scientific Announces Issuance of U.S. Patent for the Detection, Measurement and Imaging of Cancer Cells Using Nanoparticles | 05-23-13 |
| Nordion suscribe acuerdo para ceder el negocio de terapias objetivo a BTG plc | 05-23-13 |
| DVS Sciences CyTOF®????????Cytometry A 2012??????????? | 05-23-13 |
| BioTime Announces Results of Vote at Special Meeting of Shareholders | 05-23-13 |
| Ligand to Present at Upcoming Investor Conferences | 05-23-13 |
| ACT Appoints Edward Myles as Chief Financial Officer | 05-23-13 |
| Thermo Fisher Scientific Declares Quarterly Dividend | 05-23-13 |
| Covidien??????????????????????????????????????? | 05-23-13 |
| Dyax Corp. Announces Participation in Upcoming Investor Events | 05-23-13 |
| Takeda Initiates TOURMALINE-MM2 Pivotal Phase 3 Trial of MLN9708 in Patients with Newly Diagnosed Multiple Myeloma | 05-23-13 |
| Arsanis Nominates Preclinical Candidate for Staphylococcus aureus Program | 05-23-13 |
| Tufts CSDD Study Finds Adoption of Adaptive Clinical Trial Designs Is Increasing | 05-23-13 |
| miRagen Therapeutics Achieves First Milestone in Strategic Alliance with Servier | 05-23-13 |
| Biogen Idec nomina Spyros Artavanis-Tsakonas Chief Scientific Officer | 05-23-13 |
| Biogen Idec nomme Spyros Artavanis-Tsakonas conseiller scientifique en chef | 05-23-13 |
| Biogen Idec ernennt Spyros Artavanis-Tsakonas zum Chief Scientific Officer | 05-23-13 |
| Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer | 05-23-13 |
| Biogen Idec nombra Director Científico a Spyros Artavanis-Tsakonas | 05-23-13 |
| Verastem to Present at the 2013 ASCO Annual Meeting | 05-23-13 |
| ARIAD to Present at the Deutsche Bank 38th Annual Healthcare Conference | 05-23-13 |
| Advaxis Announces Filing of Proxy Statement Supplement and New Annual Meeting Date | 05-23-13 |
| Spectrum Pharmaceuticals to Present Corporate Update at the Deutsche Bank 38th Annual Health Care Conference in Boston on May 30th | 05-23-13 |
| Cancer Genetics to Present at Marcum MicroCap Conference | 05-23-13 |
| Alkermes plc Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations | 05-23-13 |
| Nordion unterzeichnet Vertrag über Verkauf seines Geschäftsbereichs Targeted Therapies an BTG plc | 05-23-13 |
| L'étude EnligHTNment de St. Jude Medical présentée lors de l'EuroPCR comme étant susceptible de changer la pratique clinique | 05-23-13 |
| KCI?V.A.C.®???????????Prevena? Peel & Place??????? | 05-23-13 |
| DiaGenic ASA: Annual General Meeting held | 05-23-13 |
| Nordion passe un accord pour céder des thérapies ciblées à BTG plc | 05-23-13 |
| One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology | 05-23-13 |
| Nordion sluit overeenkomst met BTG plc voor verkoop van bedrijfsonderdeel Targeted Therapies | 05-23-13 |
| Nordion sottoscrive accordo per cedere attività Terapie Mirate a BTG plc | 05-23-13 |
| Karolinska Development AB (publ): First patient dosed in the Phase I/II study of Umecrine Mood's candidate drug for premenstrual dysphoric disorder | 05-23-13 |
| Nordion Enters into Agreement to Divest Targeted Therapies Business to BTG plc | 05-23-13 |
| Titan Spine meldet Aufnahme neuer Mitglieder in sein Meinungsführer-Beratungsteam | 05-23-13 |
| Agilent Technologies, University of Rouen and A*STAR's Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics | 05-22-13 |
| KCI Lanza el Vendaje Prevena? Peel & Place? con Conector de Terapia V.A.C.® | 05-22-13 |
| KCI lança curativo Prevena? Peel & Place? com conector de terapia V.A.C.® | 05-22-13 |
| NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference | 05-22-13 |
| Biogen Idec to Present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference | 05-22-13 |
| KCI lance le pansement Prevena? Peel & Place? avec le connecteur de thérapie V.A.C.® | 05-22-13 |
| Titan Spine Announces New Appointments to Key Opinion Leader Advisory Team | 05-22-13 |
| Synageva BioPharma? to Present at the Jefferies 2013 Global Healthcare Conference | 05-22-13 |
| Targeted Medical Pharma to Present at Marcum MicroCap Conference | 05-22-13 |
| Promedior Presents Encouraging Results from Clinical Study of PRM-151 in Patients with Idiopathic Pulmonary Fibrosis | 05-22-13 |
| Samenvatting: KCI lanceert Prevena Peel & Place Dressing met V.A.C.® Therapy Connector | 05-22-13 |
| LABS, Inc. Announces Senior Management Promotion | 05-22-13 |
| CORRECTING and REPLACING H&Q Healthcare Investors Declares Stock Distribution | 05-22-13 |
| Further Data on STENTYS Self-Apposing Stent Reinforces Strength of Clinical Results | 05-22-13 |
| KCI lanciert Prevena? Peel & Place?-Verband mit V.A.C.® Therapy Connector | 05-22-13 |
| La Agencia Europea del Medicamento aprueba la solicitud de comercialización de sofosbuvir de Gilead para el tratamiento de la hepatitis C | 05-22-13 |
| Cognoptix Test Identifies Alzheimer's Disease via Beta Amyloid Signature in the Eyes in Proof-of-Concept Clinical Trial | 05-22-13 |
| Samenvatting: Covidien presenteert data van klinisch onderzoek waaruit blijkt dat Endoscopic Ablation Therapy het weefsel van precancerous slokdarmkanker elimineert en de progressie van de ziekte vermindert | 05-22-13 |
| Europäische Arzneimittelbehörde bestätigt Gileads Vermarktungsantrag für Sofosbuvir zur Behandlung von Hepatitis C | 05-22-13 |
| L?Agence européenne des médicaments accepte la demande d?autorisation de mise sur le marché de Gilead pour le sofosbuvir comme traitement de l?hépatite C | 05-22-13 |
| Covidien divulga dados de ensaio clínico mostrando como a terapia de ablação endoscópica elimina tecido esofágico cancerígeno e reduz de forma significante a progressão da doença | 05-22-13 |
| Research and Markets: Metabolomics Market By Applications and Indications with Forecasts from 2012 to 2017: Global market shows massive double digit growth | 05-22-13 |
| Welch Allyn Technology Provides Connectivity Between Diagnostic Devices and EMR | 05-22-13 |
| Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC) | 05-22-13 |
| KCI Launches Prevena? Peel & Place? Dressing with V.A.C.® Therapy Connector | 05-22-13 |
| Riassunto: KCI lancia la medicazione per terapia Prevena? Peel & Place? con connettore V.A.C.® | 05-22-13 |
| Clinical Data on TetraLogic Pharmaceuticals? Smac Mimetic Birinapant to Be Presented at ASCO | 05-22-13 |
| Kennedy Krieger Institute and Partek Incorporated Awarded $1.8M NIH Grant | 05-22-13 |
| Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer | 05-22-13 |
| Protalex Reports Positive Interim Review of Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis by Independent Data Safety Monitoring Committee | 05-22-13 |
| Ranbaxy Highlights Improved Business and Quality Assurance Standards | 05-22-13 |
| ?????II/III????????????????????? | 05-22-13 |
| Incyte to Present at Upcoming Investor Conferences | 05-22-13 |
| Infinity to Present at Deutsche Bank's 38th Annual Health Care Conference | 05-22-13 |
| McKesson's InterQual 2013 Deepens McKesson's Commitment to Supporting High-Quality, Efficient Care | 05-22-13 |
| Mayo Clinic Forms Joint Venture with Cancer Genetics | 05-22-13 |
| New Prescription Medical Food May Be Beneficial in Dietary Management of IBS-D | 05-22-13 |
| Resumen: El estudio EnligHTNment de St. Jude Medical destacó en el EuroPCR durante los ensayos que podría cambiar la práctica en las sesiones clínicas | 05-22-13 |
| Lo studio EnligHTNment di St. Jude Medical in primo piano al congresso EuroPCR, sperimentazione che potrebbe cambiare le sessioni di pratica clinica | 05-22-13 |
| Riassunto: Covidien annuncia i risultati della sperimentazione clinica: la terapia ablativa endoscopica elimina il tessuto esofageo precancerogeno e riduce in modo significativo la progressione della malattia | 05-22-13 |
| Salix Pharmaceuticals Announces Statistically Significant Results for Budesonide Foam in the Treatment of Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis in Two Pivotal Phase 3 Studies | 05-22-13 |
| Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting | 05-22-13 |
| NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Initial Clinical Trials of Its First Drug Candidate | 05-22-13 |
| Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression | 05-22-13 |
| Covidien presenta datos de un ensayo clínico que demuestran que la terapia de ablación endoscópica elimina el tejido precanceroso del esófago y reduce significativamente la progresión de la enfermedad | 05-22-13 |
| Covidien annonce des données d'essai clinique montrant que l'ablation endoscopique élimine le tissu précancéreux de l''sophage et réduit considérablement l'évolution de la maladie | 05-22-13 |
| Covidien gibt klinische Studienergebnisse bekannt, die zeigen, dass endoskopische Ablationstherapie präkanzeröses Speiseröhrengewebe beseitigt und das Fortschreiten der Erkrankung deutlich verlangsamt | 05-22-13 |
| Phagenesis Expands Series B Financing to $17 million | 05-22-13 |
| ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 30th | 05-22-13 |
| ?????????II/III?????????????????????????????????? | 05-22-13 |
| L?Agenzia europea per i medicinali (European Medicines Agency, EMA) convalida la domanda di Gilead di autorizzazione alla commercializzazione di sofosbuvir per il trattamento dell?epatite C | 05-22-13 |
| Raysearch and IBA to Increase Proton Therapy Precision | 05-22-13 |
| European Medicines Agency bevestigt marktaanvraag Gilead voor sofosbuvir voor de behandeling van hepatitis C-infectie | 05-22-13 |
| CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013 | 05-22-13 |
| SalutarisMD Data for Wet AMD Treatment with Long Term Positive Outcomes Presented at The Royal College of Ophthalmologists Annual Congress | 05-22-13 |
| CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd | 05-21-13 |
| Quintiles classé leader du secteur et meilleur de sa catégorie pour la qualité de ses services en recherche clinique de phase II/III | 05-21-13 |
| NPS Pharmaceuticals Prices Public Offering of Common Stock | 05-21-13 |
| Quintiles avaliada como empresa líder no setor e de mais alta qualidade de serviços em pesquisa clínica de fases II/III | 05-21-13 |
| Vince Wilfork Visits EMD Millipore's Jaffrey, NH Manufacturing Facility | 05-21-13 |
| Merck Announces $5 Billion Accelerated Share Repurchase | 05-21-13 |
| Quintiles als Branchenführer und Unternehmen mit höchster Servicequalität bei klinischen Studien der Phase II/III eingestuft | 05-21-13 |
| Quintiles obtuvo la calificación de líder en la industria y el lugar más alto en prestación de servicios de calidad en las fases II/III de investigación clínica | 05-21-13 |
| European Medicines Agency Validates Gilead's Marketing Application for Sofosbuvir for the Treatment of Hepatitis C | 05-21-13 |
| Audax Group Announces Acquisition of Chesapeake IRB | 05-21-13 |
| BIO Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy | 05-21-13 |
| Q1 Productions Hosts 2nd Annual Strengthening Patient Advocacy Relations across the Life Science Industry Conference | 05-21-13 |
| Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients with Schizophrenia Compared to Seroquel XR® (quetiapine XR) | 05-21-13 |
| Biodesix to Announce Results of VeriStrat® Biomarker Study | 05-21-13 |
| Cellectis: Compact TALENTM: the next generation of TAL effector nucleases | 05-21-13 |
| Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer | 05-21-13 |
| Transgene annonce la clôture du recrutement (120 patients) de l?étude TRAVERSE, un essai de phase 2b du virus oncolytique Pexa-Vec dans le cancer du foie | 05-21-13 |
| Cellectis : Compact TALENTM : La nouvelle génération de nucléases effectrices TAL | 05-21-13 |
| BIO Welcomes EPA Proposed Rule on New RFS2 Pathways | 05-21-13 |
| Samenvatting: Quintiles sectorleider en aan kop qua dienstenkwaliteit in fase II/III klinisch onderzoek | 05-21-13 |
| Research and Markets: Apotex Partnering 2005-2013 Report Provides an Orientation of Its Dealmaking and Business Activities | 05-21-13 |
| Riassunto: Quintiles riconosciuta come leader del settore con la qualità di servizio più elevata nelle ricerche cliniche di Fase II/III | 05-21-13 |
| ACRO Joins Coalition of Small Business Innovators | 05-21-13 |
| BIO Joins Coalition of Small Business Innovators | 05-21-13 |
| Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer | 05-21-13 |
| Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives | 05-21-13 |
| Russell Reynolds Associates Adds Sofie Qiao to San Francisco Office and Max Zuckerman to the Palo Alto Office | 05-21-13 |
| Oxygen Biotherapeutics Names Col. Charles L. Pamplin III, M.D., Chief Medical Officer | 05-21-13 |
| Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives | 05-21-13 |
| Samenvatting: Quintiles sectorleider en aan kop qua dienstenkwaliteit in fase II/III klinisch onderzoek | 05-21-13 |
| St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session | 05-21-13 |
| EnligHTNment-Studie von St. Jude Medical auf dem EuroPCR-Kongress in der Sitzung ?Trials That May Change Clinical Practice? hervorgehoben | 05-21-13 |
| Four Integrated Health Systems Form New Premier healthcare alliance Collaborative, Save $5.4 Million | 05-21-13 |
| Baxter Receives Marketing Authorization for HyQvia in European Union | 05-21-13 |
| Imprivata Appoints Rodger Weismann to Board of Directors | 05-21-13 |
| CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors | 05-21-13 |
| Quintiles Rated Industry Leader and Highest in Service Quality in Phase II/III Clinical Research | 05-21-13 |
| Medidata to Present at the 14th Annual B. Riley & Co. Investor Conference | 05-21-13 |
| Liquidia Technologies Announces Extension of Collaboration with PATH to Develop Next Generation Pneumococcal Vaccine | 05-21-13 |
| Caligor Rx Managing Director Tammy Bishop Elected to Board of Directors for Diversity Alliance for Science | 05-21-13 |
| OvaScience Publishes Article Highlighting the Role of Mitochondria in Improving Fertility Outcomes | 05-21-13 |
| Phase III results: tiotropium* Respimat® effective in symptomatic asthma patients despite at least ICS?/LABA? independent of their age, allergic status, smoking status and bronchodilator response | 05-21-13 |
| Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple Sclerosis | 05-21-13 |
| New Index of 5,000 U.S. Physicians Reveals Downward Trend In Profitability For The Year Ahead, With Healthcare Reform Fueling Top Operational Challenges | 05-21-13 |
| Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine | 05-21-13 |
| KineMed Announces an Agreement With MedImmune to Study Protein Dynamics Related to Neurodegenerative Diseases | 05-21-13 |
| Verastem to Present at Upcoming Conferences | 05-21-13 |
| Samenvatting: Biogen Idec vraagt goedkeuring aan bij FDA voor PLEGRIDY (Peginterferon Beta-1a) bij multiple sclerosis | 05-21-13 |
| From Novel Research to Innovative Medicines: GlaxoSmithKline Launches Discovery Fast Track Competition for Academic Researchers | 05-21-13 |
| Covidien's Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians | 05-21-13 |
| OncoSec Medical to Present at the Second Annual Marcum LLP MicroCap Conference | 05-21-13 |
| Research and Markets: Human Papilloma Virus Partnering 2007-2013 | 05-21-13 |
| Arthur D. Little Creates Strategy for Healthcare Launch Excellence | 05-21-13 |
| Healthcare: Neue Rezepte für Markteinführung gesucht | 05-21-13 |
| Arthur D. Little développe une stratégie d?excellence pour le lancement de nouveaux produits de santé | 05-21-13 |
| Arthur D. Little?????????????????? | 05-21-13 |
| ?????D???????????????????????? | 05-21-13 |
| Global Oil Traders Fuel Kineta's Drug Pipeline | 05-21-13 |
| RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market | 05-21-13 |
| Interview with InVivo Therapeutics? CEO to be Aired on Boston's NPR Station WBUR This Morning | 05-21-13 |
| Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million | 05-21-13 |
| Stockholm Business Region: Exclusive Showcase at BioEquity Europe 2013 in Stockholm: Meet Stockholm's Most Promising Life Science Companies | 05-21-13 |
| Biogen Idec Submits Application to FDA for Approval of PLEGRIDY? (Peginterferon Beta-1a) in Multiple Sclerosis | 05-21-13 |
| Biogen Idec presenta all'FDA una domanda di approvazione per il PLEGRIDY? (Peginterferone Beta-1a) per la sclerosi multipla | 05-21-13 |
| Biogen Idec soumet une demande auprès de la FDA pour l'approbation du PLEGRIDY? (peginterféron bêta-1a) contre la sclérose en plaques | 05-21-13 |
| Biogen Idec reicht Zulassungsantrag für PLEGRIDY? (Peginterferon Beta-1a) zur Behandlung der multiplen Sklerose bei der FDA ein | 05-21-13 |
| Biogen Idec presenta solicitud ante la FDA para aprobación de PLEGRIDY? (Peginterferón Beta-1a) sobre esclerosis múltiple | 05-21-13 |
| Cordis Showcases Cardiovascular Innovations at EuroPCR 2013 | 05-21-13 |
| Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial | 05-20-13 |
| Cancer Genetics to Attend ASCO Annual Meeting | 05-20-13 |
| Research and Markets: Genzyme Partnering 2005-2013 Available Now for Review | 05-20-13 |
| Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility | 05-20-13 |
| NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock | 05-20-13 |
| Impax Board of Directors Establishes Compliance Committee | 05-20-13 |
| ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock | 05-20-13 |
| Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine | 05-20-13 |
| Sunovion Pharmaceuticals Inc. Announces Data Showing Latuda® (lurasidone HCl) was Associated with Low Rates of Weight and Metabolic Changes in Patients with Depressive Episodes Associated with Bipolar I Disorder | 05-20-13 |
| Samenvatting: DVS Sciences CyTOF Mass Cytometer genoemd in witboek genomineerd voor de Cytometry A 2012 Best Paper Award | 05-20-13 |
| NanoString Technologies Files Registration Statement with the Securities and Exchange Commission for an Initial Public Offering | 05-20-13 |
| Elan's Response to Royalty Pharma Announcement | 05-20-13 |
| STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial | 05-20-13 |
| Piper Jaffray Expands Healthcare Investment Banking, Appoints Head of West Coast Biotechnology | 05-20-13 |
| New Diagnostics Solutions from Welch Allyn to Help Improve Patient Safety, Reduce Risk for Facilities | 05-20-13 |
| MaxCyte Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation | 05-20-13 |
| Acurian Announces Partnership Agreement with the Society for Clinical Research Sites (SCRS) | 05-20-13 |
| COPD Foundation Hosts COPD8USA Conference, Highlights Latest Clinical, Scientific and Care Delivery Issues | 05-20-13 |
| Research and Markets: Genetic Testing Market Outlook to 2017 | 05-20-13 |
| Preventing and Relieving the Relentless Ringing of Tinnitus | 05-20-13 |
| Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 05-10-13 |
| Santarus Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder | 05-10-13 |
| Cancer Genetics Announces Conference Call to Discuss First Quarter Results | 05-10-13 |
| Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain | 05-10-13 |
| Louisiana Continuing Care Hospital Launches Xenex's Infection Protection Robot | 05-10-13 |
| Acceleron's ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes | 05-10-13 |
| Secant Medical Receives MedTech Leadership Award from PACT at 20th Enterprise Awards | 05-10-13 |
| Pernix Therapeutics Reports First Quarter 2013 Financial Results | 05-10-13 |
| Samenvatting: Vertex Pharmaceuticals zendt presentaties op web uit | 05-10-13 |
| Resumen: Vertex Pharmaceuticals anuncia retransmisiones por Internet de sus presentaciones en dos conferencias para inversores | 05-10-13 |
| Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14th | 05-10-13 |
| Research and Markets: Freedom to Operate - A Practical Guide (Seminar, London) 19th July 2013 | 05-10-13 |
| ???????????????????? | 05-10-13 |
| Vertex Pharmaceuticals kündigt Webcasts seiner Präsentationen auf zwei Anlegerkonferenzen an | 05-10-13 |
| Vertex Pharmaceuticals annonce des diffusions Web de ses présentations lors de deux conférences destinées aux investisseurs | 05-10-13 |
| Riassunto: Vertex Pharmaceuticals preannuncia la trasmissione via web delle presentazioni tenute a due conferenze per gli investitori | 05-10-13 |
| Globus Medical Launches FORTIFY® I Integrated Expandable Corpectomy System | 05-09-13 |
| Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences | 05-09-13 |
| New World-First Technology Use at Saskatchewan Disease Control Laboratory | 05-09-13 |
| InSite Vision Initiates Confirmatory Phase 3 Clinical Study of BromSite? for the Reduction of Inflammation and Pain after Cataract Surgery | 05-09-13 |
| Puma Biotechnology Reports First Quarter 2013 Financial Results | 05-09-13 |
| Santarus Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder | 05-09-13 |
| Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results | 05-09-13 |
| Arrowhead Reports Fiscal 2013 Second Quarter Financial Results | 05-09-13 |
| Cytori Reports First Quarter 2013 Business and Financial Results | 05-09-13 |
| ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results | 05-09-13 |
| MannKind Corporation Reports 2013 First Quarter Financial Results | 05-09-13 |
| Advanced Cell Technology Announces 2013 First Quarter Results | 05-09-13 |
| Bacterin Announces First Quarter 2013 Revenue of $8.6 Million | 05-09-13 |
| Saskatchewan Disease Control Laboratory Selects Fluidigm BioMarkTM HD Platform to Track Infectious Agents | 05-09-13 |
| Waters Corporation Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to Be Webcast Live | 05-09-13 |
| USMD Surgeon Becomes First in D/FW to Perform Single-Site Hysterectomy | 05-09-13 |
| A Clinical Study Shows the Theracurmin®'s Safety and Potential Role in Improving Quality of Life (QOL) of Pancreatic Cancer Patients | 05-09-13 |
| SARTA MedStart Progress Report Identifies 18 New Med Tech Companies | 05-09-13 |
| Research and Markets: Recurring Questions in Biotechnology and Chemistry Case Law of the EPO Boards of Appeal (Conference, London) - 2013 | 05-09-13 |
| Senesco Announces $1.255 Million Equity Financing | 05-09-13 |
| Resumen: Phlexglobal suscribe alianza con Arkivum | 05-09-13 |
| Research and Markets: Valeant Partnering 2005-2013 - Access to Partnering Activities over the past 7 Years | 05-09-13 |
| T2 Biosystems Named 2013 SBANE New England Innovation Award Winner | 05-09-13 |
| Chris Velis, Chairman & CEO of MedCap Advisors LLC, Addresses Medtech Community at the 2013 MPO Summit | 05-09-13 |
| BioCryst to Present at Two Upcoming Investor Conferences | 05-09-13 |
| Define Vendor Site Selection Strategy to Jump-Start Phase 1 Trials | 05-09-13 |
| ISR's Risk-based Monitoring Report Offers Industry Peer-based Guidance | 05-09-13 |
| Medgenics Reports First Quarter 2013 Financial Results | 05-09-13 |
| Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Facility-Wide Physical Inventory Services | 05-09-13 |
| Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Research | 05-09-13 |
| Sagentia Delivers Alpha Prototype of New Microbial Genotyping System for PathoGenetix Inc. | 05-09-13 |
| Seattle Genetics to Present at Upcoming Investor Conferences | 05-09-13 |
| ACRO Launching New Video Series With Health Coalition Leaders | 05-09-13 |
| CytRx Reports 2013 First Quarter Financial Results | 05-09-13 |
| Dendreon Announces First Quarter 2013 Results | 05-09-13 |
| ????IPO?? | 05-09-13 |
| NPS Pharmaceuticals Reports First Quarter 2013 Financial Results | 05-09-13 |
| Onconova Completes Enrollment in ONTIME Pivotal Phase 3 Study of Rigosertib in Patients with High-risk Myelodysplastic Syndromes | 05-09-13 |
| Verastem Reports First Quarter 2013 Financial and Corporate Results | 05-09-13 |
| Synageva BioPharma? Announces One Year of Treatment Data with Sebelipase Alfa in Late Onset LAL Deficiency | 05-09-13 |
| Antares Pharma to Present at the Bank of America Merrill Lynch 2013 Healthcare Conference | 05-09-13 |
| Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 05-09-13 |
| Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in Stroke | 05-09-13 |
| Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 05-09-13 |
| Spectrum Pharmaceuticals Reports Financial Results for First Quarter 2013 | 05-09-13 |
| BioLineRx to Present at the Oppenheimer 14th Annual Israeli Conference on May 12th | 05-09-13 |
| Columbia Laboratories Reports First Quarter 2013 Financial Results | 05-09-13 |
| Bekanntgabe der Preisfestsetzung für Quintiles-Börsengang | 05-09-13 |
| Precision Therapeutics Presents Clinical Data Demonstrating Prediction for Platinum Resistance to First-Line Chemotherapy in Primary Ovarian Cancer at WAGO | 05-09-13 |
| Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure | 05-09-13 |
| InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update | 05-09-13 |
| ???????????????V.A.C. VeraFlo? Therapy????????????????????????????? | 05-09-13 |
| Quintiles annonce la fixation des prix de son premier appel public à l'épargne | 05-09-13 |
| Quintiles anuncia definição de preço de oferta pública inicial | 05-09-13 |
| Quintiles anuncia precio de oferta pública inicial | 05-09-13 |
| Riassunto: Quintiles annuncia il prezzo della propria offerta pubblica iniziale | 05-09-13 |
| Quintiles Announces Pricing of Initial Public Offering | 05-08-13 |
| Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-Related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting | 05-08-13 |
| ????????????2??????? ???????????AMD????ACU-4429 ?????2a???????ARVO????????????????? | 05-08-13 |
| Response to Planned Closure of Imaging Lab Good News Story of the Year | 05-08-13 |
| Exelixis Announces Webcasts of Upcoming Investor Conference Presentations | 05-08-13 |
| TherapeuticsMD Reports First Quarter 2013 Financial Results | 05-08-13 |
| Cubist to Present at Bank of America Merrill Lynch 2013 Healthcare Conference | 05-08-13 |
| LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 05-08-13 |
| Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas | 05-08-13 |
| GenMark Diagnostics Reports First Quarter 2013 Results | 05-08-13 |
| BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger | 05-08-13 |
| Transgenomic Reports First Quarter 2013 Financial Results | 05-08-13 |
| Ligand Reports First Quarter Financial Results | 05-08-13 |
| Simple New Test Predicts Future Risk for Serious Cardiac Events | 05-08-13 |
| Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi | 05-08-13 |
| Techulon Awarded $1.9M to Defeat 'superbugs? | 05-08-13 |
| Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein Therapeutic for Topical Treatment of Dry Eye Disease | 05-08-13 |
| Research and Markets: Computational Biology Market - Global Industry Analysis, Size, Share, Growth, Trend | 05-08-13 |
| Retrophin Names Marc L. Panoff as Chief Financial Officer | 05-08-13 |
| New Data Presented Demonstrates Ovulatory Effect of Teva Women's Health's Investigational 28-Day Oral Contraceptive | 05-08-13 |
| Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference | 05-08-13 |
| Healthx Wireless Monitoring for High-Risk Patients Reduces Costly ER Visits and Readmissions | 05-08-13 |
| Fry Construction Completes Groundbreaking Cancer Treatment Center | 05-08-13 |
| Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference | 05-08-13 |
| ??????????V.A.C. VeraFlo??????????????????? | 05-08-13 |
| Samenvatting: Onafhankelijk onderzoek heeft aangetoond dat minder patiënten met geïnfecteerde wonden geopereerd hoeven te worden na behandeling met de adjunctieve V.A.C. VeraFlo therapie | 05-08-13 |
| ??????????????????????????????????? | 05-08-13 |
| Thermo Fisher Scientific to Host Analyst Meeting | 05-08-13 |
| Systech International and Tata Consultancy Services Partner to Deliver Scalable Serialization Solutions to the Life Sciences Industry | 05-08-13 |
| Puma Biotechnology to Present at Bank of America Merrill Lynch 2013 Health Care Conference | 05-08-13 |
| Interleukin Genetics and University of North Carolina Publish Genetic Factors Predictive of Progression of Knee Osteoarthritis | 05-08-13 |
| CytRx Provides Update on Clinical Programs | 05-08-13 |
| Zalicus Secures New $25 Million Funding Commitment from Lincoln Park Capital | 05-08-13 |
| PerkinElmer Introduces New Chemical Intelligence Capabilities for Accelerating the Lead Discovery Process | 05-08-13 |
| Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet | 05-08-13 |
| Teva and Alexza Announce Teva's License to Market ADASUVE® in the U.S. | 05-08-13 |
| Selventa Strengthens Intellectual Property for System Diagnostics (SysDx?) Approach to Personalized Medicine | 05-08-13 |
| Enanta Pharmaceuticals Announces Financial Results for the Second Fiscal Quarter and Six Months Ended March 31, 2013 | 05-08-13 |
| Nimbus Discovery Announces Agreement with Shire to Co-Develop Therapies for Rare Diseases | 05-08-13 |
| Aduro Scientific Advisory Board Member Daniel A. Portnoy Elected to the National Academy of Sciences | 05-08-13 |
| LabConnect Expands North American Headquarters in Seattle | 05-08-13 |
| Cancer Genetics Announces Distribution Partnership with Nikon Instruments | 05-08-13 |
| Verastem to Present at Upcoming Conferences | 05-08-13 |
| Covidien??Mallinckrodt plc??????? | 05-08-13 |
| Idera Announces Presentation of Positive Data from Phase 2 Trial of TLR 7 and 9 Antagonist in Patients with Moderate-to-Severe Plaque Psoriasis | 05-08-13 |
| Research and Markets: Nanobiotechnology Applications, Markets and Companies - Updated 2013 Report | 05-08-13 |
| Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch Conference | 05-08-13 |
| ArQule Reports First Quarter 2013 Financial Results | 05-08-13 |
| Antares Pharma Reports First Quarter 2013 Operating and Financial Results | 05-08-13 |
| Navidea Biopharmaceuticals Announces First Quarter 2013 Results | 05-08-13 |
| Aviir Inc., Launches Complete Cardiovascular Genetic Testing | 05-08-13 |
| VGTI Florida Scientist Selected for a Peer-Review Panel for the National Institutes of Health | 05-08-13 |
| Allenex AB: ONCOlog has filed for bankruptcy | 05-08-13 |
| Good Start Genetics Announces $28 Million Financing from Capital Royalty | 05-08-13 |
| Heart Rhythm Society Kicks Off ?Cardiac Arrhythmia Awareness Month? in Colorado | 05-08-13 |
| Unabhängige Studie zeigt Rückgang von OP-Besuchen bei Patienten mit infizierten Wunden und V.A.C. VeraFlo? Begleittherapie | 05-08-13 |
| First Databank Research on Use of Structured Product Labeling to Identify Prescription Drugs With Boxed Warnings Finds Numerous Inconsistencies | 05-08-13 |
| Cell Medica Announces Treatment of First Pediatric Patient in Early Stage Clinical Trial of Cytovir ADV | 05-08-13 |
| Un estudio independiente reveló una disminución de visitas al quirófano por parte de pacientes con heridas infectadas que utilizan el tratamiento adyuvante V.A.C. VeraFlo? | 05-08-13 |
| Estudo independente apresenta redução no número de visitas em salas de operações para pacientes com feridas infectadas utilizando terapia adjuvante V.A.C. VeraFlo? | 05-08-13 |
| Une étude indépendante a montré que le nombre de passages en salle d?opération diminuait chez les patients présentant des plaies infectées lorsque la thérapie auxiliaire V.A.C. VeraFlo? était utilisée | 05-08-13 |
| DiaGenic ASA: Increase in share capital | 05-08-13 |
| Sydney Based Cellmid Acquires Japanese Advangen | 05-08-13 |
| eZono AG ernennt Graham Cox zum Vorstandsvorsitzenden | 05-08-13 |
| Fluidigm to Present at the Bank of America Merrill Lynch 2013 Health Care Conference | 05-07-13 |
| Riassunto: Uno studio indipendente ha dimostrato una riduzione del numero di visite in sala operatoria per i pazienti con ferite infette usando la terapia coadiuvante V.A.C. VeraFlo? | 05-07-13 |
| Idera Pharmaceuticals Announces Closing of Common Share Offering | 05-07-13 |
| Exelixis Announces First Quarter 2013 Financial Results | 05-07-13 |
| pSivida Corp. Announces Commercial Launch of ILUVIEN® in Germany with First Patient Treated | 05-07-13 |
| Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting | 05-07-13 |
| Synageva BioPharma? Reports First Quarter 2013 Financial Results | 05-07-13 |
| Seattle Genetics Reports First Quarter 2013 Financial Results | 05-07-13 |
| Furiex Reports First Quarter 2013 Financial Results | 05-07-13 |
| Sucampo Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operating Results | 05-07-13 |
| ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results | 05-07-13 |
| Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast | 05-07-13 |
| InSite Vision Reports First Quarter 2013 Financial Results | 05-07-13 |
| Lantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 P.M. Eastern Time | 05-07-13 |
| Firefly BioWorks Awards Three Frontiers Grants for microRNA Research | 05-07-13 |
| Infinity Reports First Quarter 2013 Financial Results and Provides Company Update | 05-07-13 |
| Xcovery Vision Presents VEGFR/PDGFR Oral Inhibitor X-82 Preliminary Data for Wet AMD at ARVO | 05-07-13 |
| CytomX Therapeutics Named a Finalist for the 2013 Red Herring Top 100 North America Award | 05-07-13 |
| Independent Study Showed Decrease in Operating Room Visits for Patients with Infected Wounds Using Adjunctive V.A.C. VeraFlo? Therapy | 05-07-13 |
| Boston Physician Awarded Master of the American College of Endocrinology | 05-07-13 |
| Dual Citizen of Switzerland and USA Awarded International Endocrinology Award | 05-07-13 |
| Research and Markets: Gene Therapy - Technologies, Markets and Companies - Updated 2013 Report | 05-07-13 |
| SpineVision® SA Raises $10m and Adds New Investors | 05-07-13 |
| BIO to Use ViS Analytics to Streamline Pediatric Clinical Research | 05-07-13 |
| Armada Health Care Chooses BusinessOne Technologies to Optimize Access, Distribution and Reimbursement Activities | 05-07-13 |
| Veeva Systems Introduces Complete, Cloud-Based Customer Master Solution for Life Sciences Companies | 05-07-13 |
| FDA Approves BIOTRONIK's Ilesto 7 ICD/CRT-D Series | 05-07-13 |
| Resumen: Graham Cox se incorpora a eZono como CEO | 05-07-13 |
| Corgenix Gains CE Mark for ReLASV® Antigen Rapid Test for Diagnosis of Lassa Fever | 05-07-13 |
| Graham Cox est nommé directeur général d?eZono | 05-07-13 |
| Vast Majority of Americans Would Want to Know if They Have a Serious Illness or Injury, Even If There Is No Cure, New Survey Shows | 05-07-13 |
| Samenvatting: Graham Cox wordt CEO bij eZono | 05-07-13 |
| Riassunto: Graham Cox entrerà in eZono in qualità di direttore generale | 05-07-13 |
| Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 14, 2013 | 05-07-13 |
| Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Exam Gloves | 05-07-13 |
| BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents? Portal Offering Additional PureStem? Human Progenitor Cells Including Those for Diabetes Research | 05-07-13 |
| Resumen: EuropaBio y Smithers Rapra desvelan el esperado programa del Foro europeo de biotecnología industrial (EFIB) del 1 al 2 de octubre, que tendrá lugar en el centro de Bruselas, en SQUARE. | 05-07-13 |
| Medidata Solutions Appoints Steven Wilhite as Chief Marketing Officer | 05-07-13 |
| Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for Autoimmune Diseases | 05-07-13 |
| FDA Grants Fast Track Designation for Cubist's Late-Stage Antibiotic Candidate | 05-07-13 |
| Genetics Policy Institute Opens Washington, D.C. Office | 05-07-13 |
| Connie Wierman is New Theorem Vice President of Biopharmaceutical Development | 05-07-13 |
| Islet Sciences Highlights Abstract at Arteriosclerosis, Thrombosis & Vascular Biology ATVB 2013 | 05-07-13 |
| Osiris Therapeutics Announces First Quarter 2013 Financial Results | 05-07-13 |
| Targacept Reports First Quarter 2013 Financial Results | 05-07-13 |
| ARIAD Reports First Quarter 2013 Financial Results and Development Progress | 05-07-13 |
| Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease | 05-07-13 |
| Resumen: Aeras, Oxford University, Okairos: la investigación de vacunas contra la tuberculosis, VIH y malaria recibe una importante ayuda | 05-07-13 |
| Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial | 05-07-13 |
| Clovis Oncology Announces First Quarter 2013 Operating Results | 05-07-13 |
| Personalis Announces Illumina CSPro Certification for Sequencing | 05-07-13 |
| Graham Cox to Join eZono as CEO | 05-07-13 |
| BioLineRx Reports First Quarter 2013 Results | 05-07-13 |
| Samenvatting: Aeras, Oxford University, Okairos: tb, hiv en malaria vaccinonderzoek krijgt grote impuls | 05-07-13 |
| OncoSec Medical to Present at the Sachs Cancer Bio Partnering Forum and Participate in a Panel Discussion on Immunotherapies and Cancer Vaccines | 05-07-13 |
| BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results | 05-07-13 |
| Department of Pathology and Microbiology at University of Nebraska Medical Center to Join PathCentral's New Digital Pathology Network | 05-07-13 |
| ?????????2????????? | 05-07-13 |
| Karo Bio: INTERIM REPORT JANUARY-MARCH 2013 | 05-07-13 |
| Aptiv Solutions to Deliver Keynote at University of Tokyo Conference on Adaptive Clinical Trials | 05-07-13 |
| Aeras, Oxford University, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost | 05-07-13 |
| Aeras, Oxford University, Okairos : la recherche de vaccins contre la tuberculose, le VIH et le paludisme bénéficie d'un gros coup de pouce | 05-07-13 |
| Riassunto: Aeras, Università di Oxford, Okairos: enorme passo avanti nella ricerca sui vaccini per tubercolosi, HIV e malaria | 05-07-13 |
| Aeras, Oxford University, Okairos: TB-, HIV- und Malaria-Impfstofferforschung erhält bedeutenden Zuschuss | 05-07-13 |
| MEDA: Interim Report, January?March 2013 | 05-07-13 |
| Aerocrine: Interim Report January - March 2013 | 05-07-13 |
| HOYA????PENTAX???????? ?????????i-scan?????OE?????? ?????????????????????? | 05-07-13 |
| U.S. Prostate Cancer Foundation to Host 2nd Annual Scientific Symposium in Cooperation with Chinese Urological Association | 05-07-13 |
| San Diego Physician Installed as President of the American College of Endocrinology | 05-06-13 |
| Illinois Based Physician Elected Treasurer of Major Physician Organization | 05-06-13 |
| Michigan Based Physician Elected Vice President of Major Physician Organization | 05-06-13 |
| pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call Information | 05-06-13 |
| Florida Physician Becomes President Elect of Major Physician Organization | 05-06-13 |
| ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Leader | 05-06-13 |
| Charles River Laboratories to Present at Baird's Growth Stock Conference | 05-06-13 |
| Santarus Reports First Quarter 2013 Financial Results | 05-06-13 |
| Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results | 05-06-13 |
| Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control | 05-06-13 |
| Etubics Platform Generates Solid Immune Response in Colorectal Cancer Patients | 05-06-13 |
| PROVENGE® (sipuleucel-T) Data Presented at An Annual Scientific Urology Meeting | 05-06-13 |
| Guided Therapeutics to Report First Quarter 2013 Results and Hold Conference Call | 05-06-13 |
| EOS imaging Announces Harley Street Installation of 3D Orthopaedic Imaging System | 05-06-13 |
| Covidien annonce les premières prévisions annuelles complètes pour Mallinckrodt plc | 05-06-13 |
| Teva Women's Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists | 05-06-13 |
| Research and Markets: Global Cardiac Catheters - Market Growth Analysis, 2009-2015 | 05-06-13 |
| Samenvatting: Samenwerking tussen SwedenBIO en partneringONE van EBD Group faciliteren samenwerking op Nordic Life Science Days 2013 | 05-06-13 |
| Resumen: La colaboración entre SwedenBIO y partneringONE® por EBD Group facilitará las alianzas en las jornadas nórdicas de ciencias de la vida 2013 (Nordic Life Science Days 2013) | 05-06-13 |
| Exactech Launches Gibralt® OCT Spinal System for Complex Cervical Thoracic Spine Procedures Now Offering Spinal Fusion Solutions For The Entire Spine | 05-06-13 |
| Breakthrough Therapy Designation from the U.S. Food and Drug Administration Granted to Investigational HCV Regimen Containing Protease Inhibitor ABT-450 | 05-06-13 |
| Ignyta and UC San Diego Researchers Find that Permanent Epigenetic Alterations Are Associated with Immune Function in Rheumatoid Arthritis | 05-06-13 |
| Kala Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor | 05-06-13 |
| BIND Therapeutics to Present at the UBS Global Healthcare Conference | 05-06-13 |
| CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma | 05-06-13 |
| Advanced Cell Technology to Host Conference Call to Discuss 2013 First Quarter Results and Provide a Corporate Update on Thursday, May 9th | 05-06-13 |
| Medidata Solutions to Present at the Jefferies 2013 Global Technology, Media & Telecom Conference | 05-06-13 |
| Senesco Announces Start of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma | 05-06-13 |
| CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model | 05-06-13 |
| KCI??????????????? | 05-06-13 |
| Covidien anuncia primera proyección anual del ejercicio fiscal 2013 de Mallinckrodt plc | 05-06-13 |
| GHS, ITOR and Selah to Transform Cancer Care with Genetic Testing | 05-06-13 |
| Cook Medical Launches Flexor® Vue? Deflecting Endoscopic System | 05-06-13 |
| Trevi Therapeutics Commences Clinical Study of Nalbuphine ER | 05-06-13 |
| Samenvatting: Covidien komt met jaarvooruitzicht voor Mallinckrodt | 05-06-13 |
| ARIAD to Present at Bank of America Merrill Lynch Healthcare Conference | 05-06-13 |
| Advaxis Announces 2013 Annual Meeting of Stockholders | 05-06-13 |
| Arrowhead Closes $36 Million Private Offering | 05-06-13 |
| Amarantus Provides Update on #C4CT Concussion Awareness Summit on June 21 in Minneapolis | 05-06-13 |
| Advaxis Announces Promotion of Dr. Robert Petit and Daniel J. O?Connor | 05-06-13 |
| Medivir: Interim Report, 1 January ? 31 March 2013* | 05-06-13 |
| Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan? Mutation Detection Tests for Patients with Metastatic Colorectal Cancer | 05-06-13 |
| Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Third Consecutive Year | 05-06-13 |
| Collaboration Between SwedenBIO and partneringONE® by EBD Group to Facilitate Partnering at Nordic Life Science Days 2013 | 05-06-13 |
| Riassunto: La collaborazione tra SwedenBIO e partneringONE® di EBD Group faciliterà il partenariato all'evento Nordic Life Science Days 2013 | 05-06-13 |
| Une collaboration entre SwedenBIO et partneringONE® par EBD Group va faciliter le partenariat dans le cadre de l'édition 2013 des Journées nordiques des sciences de la vie (Nordic Life Science Days) | 05-06-13 |
| Kooperation zwischen SwedenBIO und partneringONE® durch EBD Group zur Förderung von Partnerschaften auf den Nordic Life Science Days 2013 | 05-06-13 |
| Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds | 05-06-13 |
| Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD/17 Million Euros in Series B Financing | 05-06-13 |
| Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period | 05-06-13 |
| Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian to Be Presented by Precision Therapeutics at WAGO Annual Meeting | 05-06-13 |
| Diaverum appoints Head of Quality & Business Processes | 05-06-13 |
| Covidien meldet erstmalige Ganzjahresaussichten für Mallinckrodt plc | 05-06-13 |
| World's Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D | 05-06-13 |
| Precision BioSciences Wins Patent Infringement Lawsuit against Cellectis | 05-06-13 |
| Gilead Sciences comunica i risultati finanziari registrati nel primo trimestre dell?esercizio 2013 | 05-06-13 |
| Covidien divulga perspectiva para o primeiro ano fiscal inteiro da Mallinckrodt plc | 05-06-13 |
| Gilead Sciences gibt Finanzergebnis für erstes Quartal 2013 bekannt | 05-05-13 |
| Gilead Sciences annonce ses résultats financiers pour le premier trimestre 2013 | 05-05-13 |
| Gilead Sciences maakt financiële resultaten eerste kwartaal 2013 bekend | 05-05-13 |
| Riassunto: Covidien annuncia la prima previsione per l?intero anno relativa a Mallinckrodt plc | 05-04-13 |
| Using Sweat to Detect Diabetic Neuropathy | 05-03-13 |
| Christiana Care Health System features world-renowned Infectious Disease experts at 50th anniversary symposium | 05-03-13 |
| Study Underscores Importance of Physical Exams As Diagnostic Tool for Thyroid Cancer | 05-03-13 |
| Cause and Effect: Case Report Shows an Association between Sugar Substitutes and Common Thyroid Disorder | 05-03-13 |
| XenoPort Announces New Employment Inducement Awards | 05-03-13 |
| Covidien Announces First Full-Year Outlook for Mallinckrodt plc | 05-03-13 |
| Phlexglobal gibt Partnerschaft mit Arkivum bekannt | 05-03-13 |
| Phlexglobal annonce un partenariat avec Arkivum | 05-03-13 |
| Navidea Biopharmaceuticals to Announce First Quarter 2013 Financial Results Pre-market on Wednesday, May 8, 2013 | 05-03-13 |
| Gilead Sciences presenta resultados financieros correspondientes al primer trimestre de 2013 | 05-03-13 |
| Samenvatting: Phlexglobal meldt partnerschap met Arkivum | 05-03-13 |
| Resumen: Vidacare Corporation incrementa su fuerza de ventas en casi un 30% para favorecer la comercialización internacional | 05-03-13 |
| Samenvatting: Vidacare Corporation breidt verkoopteam uit met dertig procent ter versterking internationale vercommercialisering | 05-03-13 |
| Riassunto: Phlexglobal annuncia la partnership con Arkivum | 05-03-13 |
| MichBio Honors Member Companies Recognized as One of Michigan's 50 Companies to Watch | 05-03-13 |
| Disposable Wireless Sensor Market Shows Signs of Life ? Healthcare Shipments to Reach 5 Million in 2018, Says ABI Research | 05-03-13 |
| Gilead presenta datos provisionales del estudio de Fase 2 LONESTAR | 05-03-13 |
| Resumen: Mover los líquidos por medio del ruido permite identificar fármacos candidato que las técnicas de laboratorio tradicionales no detectan | 05-03-13 |
| Hitachi Medical Systems MRI Scanners Rated #1 for 3rd Consecutive Year in MD Buyline Report | 05-03-13 |
| Corgenix to Host Conference Call to Discuss Third Quarter Results | 05-03-13 |
